Adenovirus-mediated thymidine kinase gene transduction in human epithelial ovarian cancer cell lines followed by exposure to ganciclovir

X. W. Tong, A. Block, S. H. Chen, S. L.C. Woo, D. G. Kieback

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

In an effort to develop gene therapy for ovarian cancer efficacy and toxicity of adenovirus-mediated transfer of the HSV-TK gene followed by administration of ganciclovir were studied in two human epithelial ovarian cancer cell lines Ov-ca-2774 and Ov-ca-1225. 100% transduction was achieved in both cell lines at MOIs of 7 and 15 as demonstrated by X-Gal staining. No toxicity of virus alone was observed at MOIs up to 30. GCV was not toxic up to 200 μg/ml. Cell killing efficacy was shown to be dependent on MOI as well as GCV dose. The 'bystander effect' of ADV/RSV-TK was quantified by mixing experiments and found to be dependent on the proportion of ADV/RSV-TK positive cells as well as the GCV dosage. Similar results were observed in both cell lines. ADV/RSV-TK mediated gene therapy may be a promising approach in ovarian cancer.

Original languageEnglish
Pages (from-to)1611-1617
Number of pages7
JournalAnticancer Research
Volume16
Issue number4 A
StatePublished - Jul 1996
Externally publishedYes

Keywords

  • Adenovirus-TK
  • Gene therapy
  • Ovarian cancer
  • Suicide genes

Fingerprint

Dive into the research topics of 'Adenovirus-mediated thymidine kinase gene transduction in human epithelial ovarian cancer cell lines followed by exposure to ganciclovir'. Together they form a unique fingerprint.

Cite this